Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
281.3 AUD | +0.44% | +0.25% | -1.85% |
May. 30 | US nears deal to fund Moderna's bird flu vaccine trial, FT reports | RE |
May. 27 | US, European nations consider vaccinating workers exposed to bird flu | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.85% | 89.87B | |
-3.95% | 37.57B | |
+61.72% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+4.04% | 9.11B | |
-19.53% | 7.32B | |
+88.73% | 7.14B |
- Stock Market
- Equities
- CSL Stock
- News CSL Limited
- Jarden Research CSL’s Price Target to AU$296.02 From AU$298.57, Keeps at Overweight